Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8510)
All Articles published online
|
Publishing Process of This Article
|
May 18, 2015 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rapti I, Hadziyannis S. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues. World J Hepatol 2015; 7(8): 1064-1073 [PMID: 26052395 DOI: 10.4254/wjh.v7.i8.1064] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i8/1064.htm |
| Number | Citing Articles |
| 1 |
Jingying Qiu, Bixue Xu, Qineng Gong, Weidong Pan, Changxiao Liu, Zhengming Huang, Xiaoke Gu, Guangyi Liang. Synthesis and Biological Evaluation of Matijin‐Su Derivatives as Potential Antihepatitis B Virus and Anticancer Agents. Chemistry & Biodiversity 2016; 13(11): 1584 doi: 10.1002/cbdv.201600113
|
| 2 |
Zhengyang Guo, Junqiao Jia, Mingjie Yao, Jingting Kang, Yongfeng Wang, Xiaotong Yan, Ling Zhang, Quanjun Lv, Xiangmei Chen, Fengmin Lu. Diacylglycerol kinase γ predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma. Experimental Cell Research 2018; 373(1-2): 211 doi: 10.1016/j.yexcr.2018.11.001
|
| 3 |
Yihan Xiao, Zhigang Cui, Xiaojun Zhou, Zongxin Li, Lihua Li, Lixian Wu, Long Sun, Xiuji Cui. Molecular characterization of multiple putative novel hepatitis B virus spliced DNA from a chronic hepatitis B patient. Acta Virologica 2023; 67 doi: 10.3389/av.2023.11663
|
| 4 |
Sheng-Sen Chen, Kang-Kang Yu, Qing-Xia Ling, Chong Huang, Ning Li, Jian-Ming Zheng, Su-Xia Bao, Qi Cheng, Meng-Qi Zhu, Ming-Quan Chen. The combination of three molecular markers can be a valuable predictive tool for the prognosis of hepatocellular carcinoma patients. Scientific Reports 2016; 6(1) doi: 10.1038/srep24582
|
| 5 |
Alfredo Marzano, Alessandra Tucci, Claudia Chialà, Giorgio M. Saracco, Maurizio Fadda, Wilma Debernardi Venon. Liver stiffness-based model for portal hypertension and hepatocellular cancer risk in HBV responsive to antivirals. Minerva Gastroenterologica e Dietologica 2019; 65(1) doi: 10.23736/S1121-421X.18.02534-5
|
| 6 |
Fei Chen, Carl Freyer, Lan Gong, Amany Zekry. Gastrointestinal Diseases and their Associated Infections. 2019; : 41 doi: 10.1016/B978-0-323-54843-4.00004-0
|
| 7 |
Dian‑Xing Liu, Peng‑Peng Li, Jia‑Pei Guo, Lei‑Lei Li, Bin Guo, Hong‑Bin Jiao, Jing‑Hua Wu, Jun‑Mao Chen. Exosomes derived from HBV‑associated liver cancer promote chemoresistance by upregulating chaperone‑mediated autophagy. Oncology Letters 2018; doi: 10.3892/ol.2018.9584
|
| 8 |
Uma S. Singh, Varughese A. Mulamoottil, Chung K. Chu. 2′‐Fluoro‐6′‐methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti‐HBV agent, active against drug‐resistant HBV mutants. Medicinal Research Reviews 2018; 38(3): 977 doi: 10.1002/med.21490
|
| 9 |
Emilie Crouchet, Shen Li, Mozhdeh Sojoodi, Simonetta Bandiera, Naoto Fujiwara, Hussein El Saghire, Shijia Zhu, Tongqi Qian, Fahmida Akter Rasha, Fabio Del Zompo, Stephen C. Barrett, Eugénie Schaeffer, Marine A. Oudot, Clara Ponsolles, Sarah C. Durand, Sarani Ghoshal, Gunisha Arora, Fabio Giannone, Raymond T. Chung, Nevena Slovic, Nicolaas Van Renne, Emanuele Felli, Patrick Pessaux, Joachim Lupberger, Nathalie Pochet, Catherine Schuster, Kenneth K. Tanabe, Yujin Hoshida, Bryan C. Fuchs, Thomas F. Baumert. Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation. JCI Insight 2022; 7(13) doi: 10.1172/jci.insight.159254
|
| 10 |
Emilie Crouchet, Catherine Schuster, Thomas F. Baumert. Liver cell circuits and therapeutic discovery for advanced liver disease and cancer. Comptes Rendus. Biologies 2021; 344(3): 233 doi: 10.5802/crbiol.64
|
| 11 |
Jingwei Zeng, Douglas Macdonald, Russell Durkin, Dianne Irish, Jennifer Hart, Tanzina Haque. Opt-out testing for hepatitis B and C infections in adults attending the emergency department of a large London teaching hospital. Journal of Clinical Virology 2023; 169: 105615 doi: 10.1016/j.jcv.2023.105615
|
| 12 |
Wenfang Li, Huimin Dong, Yan Huang, Tingjin Chen, Xiangzhan Kong, Hengchang Sun, Xinbing Yu, Jin Xu, jong-Yil Chai. Clonorchis sinensis Co-infection Could Affect the Disease State and Treatment Response of HBV Patients. PLOS Neglected Tropical Diseases 2016; 10(6): e0004806 doi: 10.1371/journal.pntd.0004806
|
| 13 |
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
|
| 14 |
Barbara Testoni, David Durantel, Fabien Zoulim. Novel targets for hepatitis B virus therapy. Liver International 2017; 37(S1): 33 doi: 10.1111/liv.13307
|
| 15 |
Guillermo Aquino-Jarquin. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research. Cancer Research 2017; 77(24): 6812 doi: 10.1158/0008-5472.CAN-17-2142
|
| 16 |
Ni Lin, Aizhu Ye, Jinpiao Lin, Can Liu, Jinlan Huang, Ya Fu, Songhang Wu, Siyi Xu, Long Wang, Qishui Ou, Michael J. Loeffelholz. Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes. Journal of Clinical Microbiology 2020; 58(2) doi: 10.1128/JCM.01275-19
|
| 17 |
Jonathan Liu, Pedro Goicochea, Timothy Block, Carol L. Brosgart, Eric F. Donaldson, Oliver Lenz, Seng Gee Lim, Ed G. Marins, Poonam Mishra, Marion G. Peters, Veronica Miller. Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation. Journal of Virus Eradication 2017; 3(1): 1 doi: 10.1016/S2055-6640(20)30302-2
|
| 18 |
FrancisAjang Magaji, MarkOjogba Okolo, Z Hassan, IornumH Shambe, VictorChung Pam, AmakaNgozi Ocheke, EstherS Yiltok, Williams Golit, StephenAjen Anzaku, Martins Daloek, Jerry Ogwuche, GodwinE Imade, Christain Isichie, JsiahT Mutihir, Stephen Oguche, Oche Agbaji, Jonah Musa, SolomonAteine Sagay, AI Zoakah, SusanE Cohn. Prevalence of hepatitis B virus infection among pregnant women in Jos, Nigeria. Annals of African Medicine 2020; 19(3): 176 doi: 10.4103/aam.aam_20_19
|
| 19 |
Adane Adugna, Gebereselassie Demeke, Milkiyas Toru, Dareskedar Tsehay, Ahmed Esmael, Adane Mihret, Andargachew Mulu, Gizat Almaw. Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia. PLOS ONE 2023; 18(7): e0288355 doi: 10.1371/journal.pone.0288355
|
| 20 |
Zhongyi Shen, Chengliang Zhang, Lishuai Qu, Cuihua Lu, Mingbing Xiao, Runzhou Ni, Jinxia Liu. MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0776-3
|
| 21 |
Yaomei Tian, Die Hu, Yuhua Li, Li Yang. Development of therapeutic vaccines for the treatment of diseases. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00098-9
|
| 22 |
Helen Weidemann, Kristen Yeh, Krystal Hunter, Satyajeet Roy. Risk Factors and Comorbidities Associated With Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection. Journal of Primary Care & Community Health 2024; 15 doi: 10.1177/21501319241259413
|
| 23 |
Meng Xin, Dongfeng Feng, Beibei Yin, Yan Li. Efficacy of interferon therapy in patients with hepatitis B virus‐related primary hepatic carcinoma after transcatheter arterial chemoembolization. Precision Radiation Oncology 2018; 2(3): 76 doi: 10.1002/pro6.53
|
| 24 |
Yu-Chen Chuang, Kuen-Nan Tsai, Jing-Hsiung James Ou. Pathogenicity and virulence of Hepatitis B virus. Virulence 2022; 13(1): 258 doi: 10.1080/21505594.2022.2028483
|
| 25 |
Qiuju Huang, Xin Xiao, Xuerong Zhuang, Wenli Chen, Yanfang Huang, Jinyao Liao, Wensheng Wang, Ying Wang, Linlin Lu, Zhongqiu Liu, Jing Huang. Peripheral Circulating Exosomal-miRNAs Potentially Mediate the Sensitivity to Interferon Treatment in Chronic Hepatitis B Virus Patients. Viral Immunology 2023; doi: 10.1089/vim.2022.0130
|
| 26 |
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; : 255 doi: 10.1007/978-3-030-21540-8_13
|
| 27 |
Rahila Zannat Sadiea, Shahnaj Sultana, Bijan Mohon Chaki, Tasnim Islam, Sharmy Dash, Sharmin Akter, Md Sayeedul Islam, Taheruzzaman Kazi, Abir Nagata, Rocco Spagnuolo, Rosellina Margherita Mancina, Md Golzar Hossain. Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches. International Journal of Molecular Sciences 2022; 23(3): 1617 doi: 10.3390/ijms23031617
|
| 28 |
Yue Chen, Liang Li, Xiaoxing Qian, Yongsheng Ge, Geliang Xu. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2017; 41(2): 190 doi: 10.1016/j.clinre.2016.09.010
|
| 29 |
Yunliang Shi, Zhihua Jiang, Yichao Yang, Peiqiu Zheng, Haiyan Wei, Yuan Lin, Guoli Lv, Qingli Yang. Clonorchis sinensis infection and co-infection with the hepatitis B virus are important factors associated with cholangiocarcinoma and hepatocellular carcinoma. Parasitology Research 2017; 116(10): 2645 doi: 10.1007/s00436-017-5572-1
|
| 30 |
Yi He, Yingzhi Zhou, Huimin Wang, Xiaorong Peng, Yunan Chang, Peng Hu, Hong Ren, Hongmei Xu. The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B. BMC Pediatrics 2022; 22(1) doi: 10.1186/s12887-022-03482-0
|
| 31 |
Jonggi Choi, Young-Suk Lim. Hepatitis B Virus and Liver Disease. 2018; : 193 doi: 10.1007/978-981-10-4843-2_11
|
| 32 |
Shivaksh Ahluwalia, Divya Choudhary, Purnima Tyagi, Vijay Kumar, Perumal Vivekanandan. Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter. Journal of Biological Chemistry 2021; 297(4): 101233 doi: 10.1016/j.jbc.2021.101233
|
| 33 |
Sixing Shen, Lingyan Pan. Effect of metabolic dysfunction‑associated fatty liver disease on the risk of hepatocellular carcinoma in patients with chronic hepatitis B: A systematic review and meta‑analysis. Experimental and Therapeutic Medicine 2024; 27(3) doi: 10.3892/etm.2024.12387
|
| 34 |
Yongzhen Liu, Xuewei Qi, Zhenzhen Zeng, Lu Wang, Jie Wang, Ting Zhang, Qiang Xu, Congle Shen, Guangde Zhou, Shaomin Yang, Xiangmei Chen, Fengmin Lu. CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03070-8
|
| 35 |
Magda Rybicka, Eloi R. Verrier, Thomas F. Baumert, Krzysztof Piotr Bielawski. Polymorphisms within DIO2 and GADD45A genes increase the risk of liver disease progression in chronic hepatitis b carriers. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32753-8
|
| 36 |
En-Qiang Chen, Meng-Lan Wang, Lang Bai, Xiao-Fang Lv, Dong-Mei Zhang, Juan Wang, Ya-Chao Tao, Hong Tang. Junior Doctors’ Knowledge about Chronic Hepatitis B Guideline: A Survey Among 30 Primary Hospitals in Sichuan Province of China. Hepatitis Monthly 2017; 17(3) doi: 10.5812/hepatmon.45010
|
| 37 |
Qiufeng He, Chuangjie Mao, Zhili Chen, Fangfang Duan, Liang Huang, Rong Hu, Yang Deng, Jun Cheng, Song Yang, Yilan Zeng. Dynamic Changes of Growth and Thyroid Function in Young Children With Chronic Hepatitis B Treated With Peginterferon Monotherapy. Pediatric Infectious Disease Journal 2024; doi: 10.1097/INF.0000000000004567
|
| 38 |
Jonggi Choi, Young-Suk Lim. Hepatitis B Virus and Liver Disease. 2021; : 287 doi: 10.1007/978-981-16-3615-8_13
|
| 39 |
Kun-peng Fang, Wei Dai, Yan-Hong Ren, Ye-Chuan Xu, She-min Zhang, Ye-Ben Qian. Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2076-9
|
| 40 |
Vincent Soriano, Pablo Barreiro, Laura Benitez, Jose M. Peña, Carmen de Mendoza. New antivirals for the treatment of chronic hepatitis B. Expert Opinion on Investigational Drugs 2017; 26(7): 843 doi: 10.1080/13543784.2017.1333105
|
| 41 |
Xiao-Fei Zhang, Jie Chao, Qiu-Zhong Pan, Ke Pan, De-Sheng Weng, Qi-Jing Wang, Jing-Jing Zhao, Jia He, Qing Liu, Shan-Shan Jiang, Chang-Long Chen, Hong-Xia Zhang, Jian-Chuan Xia. Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget 2015; 6(38): 40920 doi: 10.18632/oncotarget.5712
|
| 42 |
Magda Rybicka, Piotr Stalke, Krzysztof Piotr Bielawski. Current molecular methods for the detection of hepatitis B virus quasispecies. Reviews in Medical Virology 2016; 26(5): 369 doi: 10.1002/rmv.1897
|
| 43 |
Mahamadou Diakite, Kathryn Shaw-Saliba, Chuen-Yen Lau. Malignancy and viral infections in Sub-Saharan Africa: A review. Frontiers in Virology 2023; 3 doi: 10.3389/fviro.2023.1103737
|
| 44 |
Somenath Datta, Debanjali Dasgupta, Alip Ghosh, Suchandrima Ghosh, Alak Manna, Simanti Datta, Mitali Chatterjee, Abhijit Chowdhury, Soma Banerjee. Oncogenic potential of hepatitis B virus subgenotype D1 surpasses D3: significance in the development of hepatocellular carcinoma. Carcinogenesis 2018; 39(2): 283 doi: 10.1093/carcin/bgx145
|